[Preliminary study of new imaging agent, 99mTc-Rituximab, for sentinel lymph node biopsy of primary breast cancer].
Jinfeng Li(Hebei Medical University), Benyao Lin(Ministry of Education), Tao Ouyang(Peking University), Xuejuan Wang(Shenyang Institute of Automation), Tianfeng Wang(Peking University), Baohe Lin, Zhaoqing Fan(Daqing Oilfield General Hospital), Zhi Yang(Peking University)
PubMed
May 1, 2006
Cited by 5
Related Papers
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272
Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
|Journal of Medicinal Chemistry|2013|221
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
|Journal of Clinical Oncology|2009|218
A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its Inhibitors
|Medicinal Research Reviews|2015|181
Covalent targeted radioligands potentiate radionuclide therapy
|Nature|2024|165